Japan Hotel Rates Hit Record as Western Tourists Fill Gap Left by Chinese Visitors Lenovo Shares Surge Nearly 20 as Record Earnings Highlight AI Revenue Surge Ken Griffin Warns Deeply Triggering Inflation Still Hurting Americans on Everyday Items The American Dream Under Strain Rising Home Costs Across Three Generations IBM Gains 27 Billion in Market Cap After Trumps 2 Billion Quantum Computing Push SGX RegCo Gives Suspended Firms Three Years to Resume Trading or Face Delisting EGP Q1 2026 Earnings EPS Beats Estimates by 681 Amid Flat Stock Movement AYTU Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges BZ Q1 2026 Earnings EPS Beats Estimates Modestly Despite Flat Revenue Disclosure Gap Inc GAP Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Uptick Mativ Holdings MATV Q1 2026 Earnings EPS Surge of 194 Surprise Despite Flat Revenue Outlook DTE Energy Q1 2026 Earnings Earnings Miss Estimates as Costs Pressure Results Provident Financial Holdings PROV Holds Steady Near Key Resistance A Narrow Trading Range Emerges Zevia PBC ZVIA Slides 58 as Weak Volume and Sector Headwinds Test NearTerm Support Service Properties Trust SVC Rises 117 as Stock Tests Resistance Near 182 Willow Lane Acquisition Corp II Unit WLIIU Holds Steady at 1018 as Resistance Level Becomes Key Saratoga Investment Corp SAR Holds Steady at 2223 Amid Tight Trading Range HFCL Shares Surge 140 on Strong Earnings and Export Orders OFG Q1 2026 Earnings EPS Smashes Estimates Stock Rises 05 Columbus Circle Capital Corp II CMII Holds Steady Near 990 With Minimal Price Movement RITM Q1 2026 Earnings Modest EPS Beat Highlights Steady Portfolio Performance MRK Q1 2026 Earnings EPS Surprise on a Loss Stock Declines 22 MSBI Q1 2026 Earnings Significant EPS Beat Driven by Strong Operational Performance TruBridge TBRG Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges MPLT Q1 2026 Earnings WiderThanExpected Loss and Stock Decline Amid ClinicalStage Pipeline Development AerCap Holdings NV AER Q1 2026 Earnings Massive EPS Beat Despite Stock Decline Telomir Pharmaceuticals Q4 2025 Earnings EPS Misses Wide Estimate as Development Costs Mount